🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A recently completed trial of weekly injections of 17 alpha hydroxyprogeste...
Status
Completed
Location
University of Alabama - Birmingham
Start Date
2005-02
Trial ID
NCT00135902
This is a phase III, double-masked, placebo-controlled, randomized controll...
Status
Completed
Location
Kamwala District Clinic
Start Date
2018-02-07
Trial ID
NCT03297216
The aim of the study is to assess the efficacy of 17-hydroxyprogesterone ca...
Status
Completed
Location
Ain shams university
Start Date
2018-01-10
Trial ID
NCT04807543
Treatments Being Tested
As part of the continuing effort to study the benefit and risks of 17P and ...
Status
Completed
Location
Drug Research & Analysis Corporation
Start Date
2009-10
Trial ID
NCT01004029
Treatments Being Tested
This study will evaluate the levels of hydroxyprogesterone caproate and it'...
Status
Completed
Location
Altus Research, Inc.
Start Date
2013-07
Trial ID
NCT01899846
Treatments Being Tested
This is a randomized controlled trial comparing weekly intramuscular inject...
Status
Completed
Location
University of Oklahoma Health Sciences Center
Start Date
2006-10
Trial ID
NCT00579553
Treatments Being Tested
The objective of the study is to determine if a weekly dose of 17 hydroxypr...
Status
Completed
Location
University of South Alabama Medical Center
Start Date
2011-10
Trial ID
NCT01119963
Treatments Being Tested
Objective: This trial would evaluate the clinical effectiveness of Progeste...
Status
Completed
Location
University of Modena and Reggio Emilia
Start Date
2010-02
Trial ID
NCT01178788
Treatments Being Tested
Women pregnant with twins or triplets are at high risk of preterm birth, ye...
Status
Completed
Location
University of Alabama - Birmingham
Start Date
2004-04
Trial ID
NCT00099164
Treatments Being Tested